Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings
Suzanne Pickering, Gilberto Betancor, Rui Pedro Galão, Blair Merrick, Adrian W. Signell, Harry D. Wilson, Mark Tan Kia Ik, Jeffrey Seow, Carl Graham, Sam Acors, Neophytos Kouphou, Kathryn J.A. Steel, Oliver Hemmings, Amita Patel, Gaia Nebbia, Sam Douthwaite, Lorcan O’Connell, Jakub Luptak, Laura E. McCoy, Philip Brouwer, Marit J. van Gils, Rogier W. Sanders, Rocio Martinez Nunez, Karen Bisnauthsing, Geraldine O’Hara, Eithne MacMahon, Rahul Batra, Michael H. Malim, Stuart J.D. Neil, Katie J. Doores, Jonathan D. Edgeworth
medRxiv 2020.06.02.20120345; doi: https://doi.org/10.1101/2020.06.02.20120345